First human trial for coronavirus vaccine begins Monday in the US

[babylonsister]

First human trial for coronavirus vaccine begins Monday in the US
Published Mon, Mar 16 2020 1:38 PM EDT
Updated Moments Ago
Berkeley Lovelace Jr.


The first human trial testing a potential vaccine to prevent COVID-19 began Monday, U.S. health officials confirmed.

Finding "a safe and effective vaccine" to prevent infection from the new coronavirus "is an urgent public health priority," Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said in a statement Monday. "This Phase 1 study, launched in record speed, is an important first step toward achieving that goal."

The National Institutes of Health, an agency within the Department of Health and Human Services, has been fast-tracking work with biotech company Moderna to develop a vaccine using the genetic sequence of the new coronavirus. The trial is taking place at the Kaiser Permanente Washington Health Research Institute in Seattle, Washington, where COVID-19 cases have surged and authorities have banned mass gatherings. The early-stage, or phase 1, trial will test the vaccine on 45 males and non-pregnant females between the ages of 18 and 55, according to trial details on NIH's website.

There are no proven therapies for the latest outbreak, which has killed at least 6,513 and sickened nearly 170,000 people worldwide since emerging from the Chinese city of Wuhan less than three months ago.

Hopes to get a vaccine to market are high, but doctors are setting expectations low for how quickly it can happen. Developing, testing and reviewing any potential vaccine is a long, complex and expensive endeavor that could take months or even years, global health experts say. Before researchers can begin human trials, they must have a firm understanding of the pathogen, run safety tests and find enough human volunteers.

The early-stage trial will be led by Dr. Lisa Jackson, a senior investigator at Kaiser. Study participants will receive two doses of the vaccine via intramuscular injection in the upper arm approximately 28 days apart, NIH said. Each participant will be assigned to receive a 25 microgram, 100 mcg or 250 mcg dose at both vaccinations, with 15 people in each dose cohort, the agency said.

"This work is critical to national efforts to respond to the threat of this emerging virus," Jackson said. "We are prepared to conduct this important trial because of our experience as an NIH clinical trials center since 2007."

more...

https://www.cnbc.com/amp/2020/03/16/first-human-trial-for-coronavirus-vaccine-begins-monday-in-the-us.html?fbclid=IwAR2k63FUaOdGpABiL_pdzvSvwD9qKaOtLMCj2uQU_mTVbnwcdEowwgVb3Zo

[Dream Girl]

1. This it just to give Trump something to crow about at his next hostage press conference

All optics at this point. Just watch

[intrepidity]

2. I doubt it

The decade of research on SARS is getting put to good use. Both viruses have the same target site.

I'm optimistic.

[Dream Girl]

4. I didn't ay it was true. In fact I'm sure it's total li.

Rmeber he tried to get right that German company’s IP hoping to stage a prs conference lik one one.when that fell though h went to Plan B...just lie.

[intrepidity]

6. Oh, well. That totally goes without saying

He tries to take credit for anything positive, no matter how far removed he was.

And avoids blame just as strenuously.

[intrepidity]

7. He did just that

I just watched it

[BeckyDem]

3. K&R Hopeful here.

[Dream Girl]

5. Don't be.

[babylonsister]

8. Kaiser is spearheading this one, not iq45/the

government. They have profit motive in mind, but this is their business. Don't be a buzzkill; you don't know.

[TheBlackAdder]

9. It should be made with fetal stem cells, so crazy fundies will refuse the shot.